Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Masimo ( (MASI) ) just unveiled an announcement.
On September 23, 2025, Masimo completed the sale of its consumer audio business, Sound United, to HARMAN International for approximately $328 million in cash. This transaction marks a strategic move for Masimo to focus on its core professional healthcare business, with plans to use the proceeds for share repurchases, thereby enhancing growth and delivering stronger margins.
The most recent analyst rating on (MASI) stock is a Buy with a $180.00 price target. To see the full list of analyst forecasts on Masimo stock, see the MASI Stock Forecast page.
Spark’s Take on MASI Stock
According to Spark, TipRanks’ AI Analyst, MASI is a Neutral.
Masimo’s overall stock score is primarily impacted by its financial challenges and bearish technical indicators. However, strong earnings call highlights and strategic corporate events provide some positive outlook.
To see Spark’s full report on MASI stock, click here.
More about Masimo
Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, automation, and connectivity solutions. Masimo’s mission is to empower clinicians to transform patient care, with their technologies being used on more than 200 million patients worldwide each year.
Average Trading Volume: 696,468
Technical Sentiment Signal: Sell
Current Market Cap: $7.72B
For an in-depth examination of MASI stock, go to TipRanks’ Overview page.